RNZ's Kathryn Ryan talks to Malaghan Institute Clinical Director Dr Rob Weinkove about its CAR T-cell clinical trial, what a recent commercial deal with global pharmaceutical Dr. Reddy's means and his ambition to see this become a mainstream treatment.
Comments
Couldn’t Load Comments
It looks like there was a technical problem. Try reconnecting or refreshing the page.
Comments